vs

Side-by-side financial comparison of FIRST NATIONAL CORP (FXNC) and IRIDEX CORP (IRIX). Click either name above to swap in a different company.

FIRST NATIONAL CORP is the larger business by last-quarter revenue ($24.0M vs $14.7M, roughly 1.6× IRIDEX CORP). On growth, FIRST NATIONAL CORP posted the faster year-over-year revenue change (-3.4% vs -69.7%). Over the past eight quarters, FIRST NATIONAL CORP's revenue compounded faster (26.8% CAGR vs 11.9%).

VA Tech Wabag Ltd. is an Indian multinational company focussed on desalination and water treatment for municipal and industrial users. Founded in Breslau in 1924, the company is headquartered in Chennai.

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

FXNC vs IRIX — Head-to-Head

Bigger by revenue
FXNC
FXNC
1.6× larger
FXNC
$24.0M
$14.7M
IRIX
Growing faster (revenue YoY)
FXNC
FXNC
+66.4% gap
FXNC
-3.4%
-69.7%
IRIX
Faster 2-yr revenue CAGR
FXNC
FXNC
Annualised
FXNC
26.8%
11.9%
IRIX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FXNC
FXNC
IRIX
IRIX
Revenue
$24.0M
$14.7M
Net Profit
$5.5M
Gross Margin
37.2%
Operating Margin
28.8%
Net Margin
23.0%
Revenue YoY
-3.4%
-69.7%
Net Profit YoY
689.9%
EPS (diluted)
$0.60

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FXNC
FXNC
IRIX
IRIX
Q4 25
$24.0M
$14.7M
Q3 25
$22.8M
$12.5M
Q2 25
$22.4M
$13.6M
Q1 25
$21.1M
$11.9M
Q4 24
$24.8M
$12.7M
Q3 24
$15.0M
$11.6M
Q2 24
$14.2M
$12.6M
Q1 24
$14.9M
$11.8M
Net Profit
FXNC
FXNC
IRIX
IRIX
Q4 25
$5.5M
Q3 25
$5.5M
$-1.6M
Q2 25
$5.1M
$-994.0K
Q1 25
$1.6M
$-1.7M
Q4 24
$-933.0K
$-834.0K
Q3 24
$2.2M
$-1.9M
Q2 24
$2.4M
$-2.7M
Q1 24
$3.2M
$-3.5M
Gross Margin
FXNC
FXNC
IRIX
IRIX
Q4 25
37.2%
Q3 25
32.1%
Q2 25
34.5%
Q1 25
42.5%
Q4 24
44.0%
Q3 24
37.3%
Q2 24
40.7%
Q1 24
37.9%
Operating Margin
FXNC
FXNC
IRIX
IRIX
Q4 25
28.8%
Q3 25
29.9%
-11.3%
Q2 25
28.2%
-6.9%
Q1 25
9.0%
-1.7%
Q4 24
-29.0%
-3.9%
Q3 24
18.7%
-16.1%
Q2 24
22.0%
-20.9%
Q1 24
26.9%
-28.0%
Net Margin
FXNC
FXNC
IRIX
IRIX
Q4 25
23.0%
Q3 25
24.3%
-12.6%
Q2 25
22.5%
-7.3%
Q1 25
7.6%
-14.2%
Q4 24
-14.4%
-6.6%
Q3 24
15.0%
-16.7%
Q2 24
17.2%
-21.2%
Q1 24
21.5%
-29.5%
EPS (diluted)
FXNC
FXNC
IRIX
IRIX
Q4 25
$0.60
Q3 25
$0.62
$-0.09
Q2 25
$0.56
$-0.06
Q1 25
$0.18
$-0.10
Q4 24
$-0.26
$-0.05
Q3 24
$0.36
$-0.12
Q2 24
$0.39
$-0.16
Q1 24
$0.51
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FXNC
FXNC
IRIX
IRIX
Cash + ST InvestmentsLiquidity on hand
$160.9M
$6.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$186.2M
Total Assets
$2.0B
$29.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FXNC
FXNC
IRIX
IRIX
Q4 25
$160.9M
$6.0M
Q3 25
$189.3M
$5.6M
Q2 25
$194.3M
$6.8M
Q1 25
$206.0M
$7.2M
Q4 24
$162.9M
$2.4M
Q3 24
$126.5M
$3.9M
Q2 24
$135.6M
$4.1M
Q1 24
$5.4M
Total Debt
FXNC
FXNC
IRIX
IRIX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$1.0M
Q3 24
$1.4M
Q2 24
Q1 24
Stockholders' Equity
FXNC
FXNC
IRIX
IRIX
Q4 25
$186.2M
Q3 25
$181.2M
$4.7M
Q2 25
$173.5M
$6.1M
Q1 25
$168.7M
$852.0K
Q4 24
$166.5M
$2.1M
Q3 24
$125.1M
$2.6M
Q2 24
$119.9M
$4.2M
Q1 24
$117.8M
$6.5M
Total Assets
FXNC
FXNC
IRIX
IRIX
Q4 25
$2.0B
$29.2M
Q3 25
$2.0B
$28.4M
Q2 25
$2.0B
$31.6M
Q1 25
$2.0B
$34.2M
Q4 24
$2.0B
$29.1M
Q3 24
$1.5B
$30.2M
Q2 24
$1.5B
$31.2M
Q1 24
$1.4B
$34.1M
Debt / Equity
FXNC
FXNC
IRIX
IRIX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.48×
Q3 24
0.53×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FXNC
FXNC
IRIX
IRIX
Operating Cash FlowLast quarter
$25.1M
Free Cash FlowOCF − Capex
$20.9M
FCF MarginFCF / Revenue
87.3%
Capex IntensityCapex / Revenue
17.4%
Cash ConversionOCF / Net Profit
4.56×
TTM Free Cash FlowTrailing 4 quarters
$34.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FXNC
FXNC
IRIX
IRIX
Q4 25
$25.1M
Q3 25
$8.4M
$-1.2M
Q2 25
$4.7M
$-397.0K
Q1 25
$3.5M
$-1.1M
Q4 24
$-22.2M
$-1.2M
Q3 24
$6.1M
$-3.1M
Q2 24
$3.6M
$-1.3M
Q1 24
$4.7M
$-1.6M
Free Cash Flow
FXNC
FXNC
IRIX
IRIX
Q4 25
$20.9M
Q3 25
$6.8M
$-1.2M
Q2 25
$4.1M
$-410.0K
Q1 25
$3.0M
$-1.2M
Q4 24
$-25.5M
$-1.2M
Q3 24
$4.9M
$-3.1M
Q2 24
$3.0M
Q1 24
$4.4M
$-1.7M
FCF Margin
FXNC
FXNC
IRIX
IRIX
Q4 25
87.3%
Q3 25
30.0%
-9.4%
Q2 25
18.3%
-3.0%
Q1 25
14.5%
-9.8%
Q4 24
-102.8%
-9.8%
Q3 24
33.0%
-26.5%
Q2 24
21.0%
Q1 24
29.5%
-14.0%
Capex Intensity
FXNC
FXNC
IRIX
IRIX
Q4 25
17.4%
Q3 25
7.0%
0.1%
Q2 25
2.6%
0.1%
Q1 25
2.3%
0.1%
Q4 24
13.3%
0.1%
Q3 24
8.1%
0.0%
Q2 24
4.6%
0.0%
Q1 24
2.0%
0.0%
Cash Conversion
FXNC
FXNC
IRIX
IRIX
Q4 25
4.56×
Q3 25
1.52×
Q2 25
0.93×
Q1 25
2.21×
Q4 24
Q3 24
2.73×
Q2 24
1.49×
Q1 24
1.47×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons